Galacto-oligosaccharide (GOS) prebiotic minimizes initial antibiotic disruption of faecal microflora and enhances recovery of microbiota during fidaxomicin therapy in an in vivo murine model.
Proceedings article published in 2015 by
G. Tzortzis,
P. Thommes,
A. Sattar,
P. Warn,
Chris Longshaw
